TITLE

Review: Evidence from observational studies, but not randomized trials, suggests that long-term aspirin prevents colorectal cancer: COMMENTARY

AUTHOR(S)
Lebwohl, Benjamin; Neugut, Alfred I.
PUB. DATE
July 2007
SOURCE
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The authors reflect on a study, conducted by C. Dubá and colleagues, which focuses on the effectiveness of aspirin in preventing colorectal cancer. The authors view that Dubá and colleagues highlight notable discrepancies between randomized controlled trials (RCTs) and observational studies regarding aspirin's efficacy as a chemopreventive agent. They opine that individuals prescribed aspirin or other NSAIDs for other conditions may derive a chemopreventive effect.
ACCESSION #
25913653

 

Related Articles

  • Aspirin in the Prevention of Colorectal Cancer. Garewal, Harinder S. // Annals of Internal Medicine;8/15/94, Vol. 121 Issue 4, p303 

    Editorial. Discusses the approaches to decreasing the morbidity and mortality from colorectal cancer. Information on chemoprevention; Side effects of nonsteroidal anti-inflammatory drugs; Appeal of aspirin as a viable option for widespread use.

  • Can Daily Aspirin Prevent Colorectal Adenomas? Sadovsky, Richard // American Family Physician;2/1/2004, Vol. 69 Issue 3, p739 

    Discusses studies on the role of aspirin in preventing colorectal adenomas, published in the August 2003 issue of the journal "Gastroenterology." "Daily Soluble Aspirin and Prevention of Colorectal Adenoma Recurrence: One-year Results of the APACC Trial," by R. Benamouzig et al.; "Will an...

  • Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer. Chan, Andrew T.; Giovannucci, Edward L.; Meyerhardt, Jeffrey A.; Schernhammer, Eva S.; Curhan, Gary C.; Fuchs, Charles S. // JAMA: Journal of the American Medical Association;8/24/2005, Vol. 294 Issue 8, p914 

    Context Randomized trials of short-term aspirin use for prevention of recurrent colorectal adenoma have provided compelling evidence of a causal relationship between aspirin and colorectal neoplasia. However, data on long-term risk of colorectal cancer according to dose, timing, or duration of...

  • NSAID use associated with lower colorectal cancer mortality rates among postmenopausal women.  // Biomedical Market Newsletter;10/26/2011, Vol. 21, p264 

    The article reports on a study regarding the utilization of nonsteroidal anti-inflammatory drugs (NSAIDS) in postmenopausal women. The researchers have evaluated 160,143 postmenopausal women with association between aspirin and nonaspirin NSAID use and colorectal cancer mortality. Result shows...

  • Clinical digest. Chance of developing colorectal cancer reduced by aspirin.  // Nursing Standard;10/27/2010, Vol. 25 Issue 8, p16 

    The article offers information on the study "Effect of Aspirin and NSAIDs on Risk and Survival From Colorectal Cancer," by F. V. N. Din and colleagues that was published in a 2010 issue of "Gut."

  • Summaries for Patients. Associations Between the Use of Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs and Colorectal Cancer Risk.  // Annals of Internal Medicine;9/1/2015, Vol. 163 Issue 5, pI-44 

    The article focuses on the study related to the associations between nonaspirin nonsteroidal antiinflammatory drugs (NSAIDs) and risk for colorectal cancer. Topics dsiucssed include diagnosis of colorectal cancer in adults; use of logistic regression by researchers; and use of low-dose aspirin...

  • Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high-risk atherothrombosis.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p33 

    The article presents information on a clinical trial to assess the effectiveness of clopidogrel and aspirin for the prevention of atherothrombosis. The study was conducted by D.L. Bhatt, K.A. Fox and W. Hacke on 15,603 patients in the age group of 45-64 years of age who had multiple...

  • Aspirin plus extended-release dipyridamole and clopidogrel were similarly effective for preventing recurrent stroke. Sacco, R. L. // Evidence Based Medicine;Apr2009, Vol. 14 Issue 2, p46 

    The article discusses the study of similar effectiveness of aspirin and plus extended-release dipyridamole (ERDP) and clopidogrel in the prevention of recurrent stroke in the U.S. The patients having the similar usage had an ischaemic stroke previously were notably stable clinically and...

  • Patient-oriented evidence that matters.  // JAAPA: Journal of the American Academy of Physician Assistants (;Apr2010, Vol. 23 Issue 4, p56 

    The article offers information on two medical research along with questions on the effectiveness of aspirin to prevent fetal loss, and the effect of an early intervention in toddlers with autism. It states that the rate of live births was higher in women being treated with herapin plus aspirin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics